CHICAGO/NEW YORK - With painstaking effort, a group of Chicago hospitals has managed to cut by half the number of infections caused by an especially deadly type of superbug. Now U.S. health officials want that kind of campaign to go national.
MONROVIA - Liberia called upon Ebola survivors on Sunday to extend a period of sexual abstinence or protected sex beyond an already advised three months following their recovery, amid fears the country's latest case may have resulted from sexual transmission.
GAITHERSBURG, Md. - Paramedic Dean Elliott rummaged through the ambulance's emergency kit and pulled out a pint-sized red power drill, a tool whose use was honed on the battlefields of Iraq and Afghanistan.
LONDON - GlaxoSmithKline has reached a deal with the British government to supply a new meningitis B vaccine, following a lengthy stand-off over price with the product's previous owner Novartis.
CONAKRY - Guinea's President Alpha Conde announced on Saturday new emergency measures enabling authorities to restrict movements in western Guinea where Ebola transmission continues a year after the epidemic was declared.
FREETOWN - Police fired tear gas at an angry crowd fighting over food supplies in Sierra Leone on Saturday, while other residents defied a three-day national lockdown that the government hopes will accelerate the end of the Ebola epidemic. | Video
WASHINGTON - In her final speech after six years as commissioner of the U.S. Food and Drug Administration, Dr. Margaret Hamburg defended the agency's drug approval standards against critics seeking weaker regulatory standards.
CHICAGO - The U.S. Department of Agriculture on Saturday confirmed the third infection of a virulent strain of avian flu in a commercial poultry flock in Minnesota, the nation's top turkey-producing state.
WASHINGTON - The Senate will wait more than two weeks before acting on a bill to permanently fix the flawed formula for reimbursing Medicare physicians, after an April 1 deadline to start a 21 percent cut in payment rates.
- The United States Food and Drug Administration rejected Adamis Pharmaceuticals Corp's injection for treating severe allergic reactions, the company said.